Nordon IM, Hincheliffe RJ, Loftus IM, et al. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011;8(2):92-202.
DOI: 10.1038/nrcardio.2010.180
Sandford RM, Bown MJ, London NJ, et al. The genetic basis of abdominal aortic aneurysms: a review. Eur J Vasc Endovasc Surg 2007;33(4):381-90.
DOI: 10.1016/j.ejvs.2006.10.025
Forsdahl SH, Singh K, Solberg S, et al. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001. Circulation 2009;119:2202-8.
DOI: 10.1161/CIRCULATIONAHA.108.817619
Lindholt JS, Sørensen J, Søgaard R, et al. Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial. Br J Surg 2010;97(6):826-34.
DOI: 10.1002/bjs.7001
Sidawy AN, Perler BA, et al. Rutherford's Vascular Surgery and Endovascular Therapy. Tenth edition. Elsevier; 2022.
Hellenthal FAMV, Buurman WA, Wodzig WKWH, et al. Biomarkers of AAA progression. Part1: extracellular matrix degeneration. Nat Rev Cardiol 2009;6(7):464-74.
DOI: 10.1038/nrcardio.2009.80
Michel JB, Martín-Ventura J-L, Egido J, et al. Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans. Cardiovasc Res 2011;90(1):18-27.
DOI: 10.1093/cvr/cvq337
Hellenthal FA, Buurman WA, Wodzig WK, et al. Biomarkers of AAA progression. Part2: inflammation. Nat Rev Cardiol. 2009; 6(8):443-52.
Vardulaki KA, Walker NM, Day NE, et al. Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br J Surg 2000;87:195-200.
DOI: 10.1046/j.1365-2168.2000.01353.x
Boese AC, Chang L, Ying KJ, et al. Sex differences in abdominal aortic aneurysms. Am J Physiol Heart Circ Physiol 2018;314:1137-52.
DOI: 10.1152/ajpheart.00519.2017
Ogata T, MacKean GL, Cole CW, et al. The lifetime prevalence of abdominal aortic aneurysms among siblings of aneurysm patients is eightfold higher than among siblings of spouses: an analysis of 187 aneurysm families in Nova Scotia, Canada. J Vasc Surg 2005;42:891-7.
DOI: 10.1016/j.jvs.2005.08.002
Orriols M, Varona S, Martí-Pàmies I, et al. Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics. Cardiovasc Res 2016;110:431-42.
DOI: 10.1093/cvr/cvw082
Jin J, Arif B, García-Fernández F, et al. Novel mechanism of aortic aneurysm development in mice associated with smoking and leukocytes. Arterioscler Thromb Vasc Biol 2012;32:2901-9.
DOI: 10.1161/ATVBAHA.112.300208
Brady AR, Thompson SG, Fowkes FG, et al. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004;110:16-21.
DOI: 10.1161/01.CIR.0000133279.07468.9F
Freiberg MS, Arnold AM, Newman AB, et al. Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events: 10-year follow-up data from the Cardiovascular Health Study. Circulation 2008;117:1010-7.
DOI: 10.1161/CIRCULATIONAHA.107.720219
Golledge J, Van Bockxmeer F, Jamrozik K, et al. Association between serum lipoproteins and abdominal aortic aneurysm. Am J Cardiol 2010;105:1480-4.
DOI: 10.1016/j.amjcard.2009.12.076
Raffort J, Lareyre F, Clément M, et al. Diabetes and aortic aneurysm: current state of the art. Cardiovasc Res 2018;114:1702-13.
DOI: 10.1093/cvr/cvy174
Rhea J, Molinaro RJ. Cancer biomarkers: surviving the journey from bench to bedside. MLO Med Lab Obs 2011;43:10-2.
Bath MF, Gokani VJ, Sidloff DA, et al. Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm. Br J Surg 2015;102:866-72.
DOI: 10.1002/bjs.9837
Golledge J, Muller R, Clancy P, et al. Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. Eur Heart J 2011;32(3):354-64.
DOI: 10.1093/eurheartj/ehq171
Sangiorgi G, D'Averio R, Mauriello A, et al. Plasma levels of metalloproteinases-3 and -9 as markers of successful abdominal aortic aneurysm exclusion after endovascular graft treatment. Circulation 2001;104(12 Supl.1):1288-95.
DOI: 10.1161/circ.104.suppl_1.I-288
Ramos-Mozo P, Madrigal-Matute J, Vega de Céniga M, et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 2012;220(2):552-6.
DOI: 10.1016/j.atherosclerosis.2011.11.023
Folsom AR, Yao L, Alonso A, et al. Circulating biomarkers and abdominal aortic aneurysm incidence: The atherosclerosis risk in communities (ARIC) study. Circulation 2015;132(7):578-85.
DOI: 10.1161/CIRCULATIONAHA.115.016537
Fernandez KS, Brum DG, Sandrim VC, et al. Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease. J Neuroinmunol 2009;214:128-31.
DOI: 10.1016/j.jneuroim.2009.07.004
Newby AC. Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2008;28:2108-14.
DOI: 10.1161/ATVBAHA.108.173898
Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 2009;27:5287-97.
DOI: 10.1200/JCO.2009.23.5556
Takagi H, Manabe H, Kawai N, et al. Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a metaanalysis. Interact Cardiovasc Thorac Surg 2009;9:437-40.
DOI: 10.1510/icvts.2009.208835
Watanabe T, Sato A, Sawai T, et al. The elevated level of circulating matrix metalloproteinase-9 In patients with abdominal aortic aneurysms dcreased to levels equal to those of healthy controls after an aoric repair. Ann Vasc Surg 2006;20:317-21.
DOI: 10.1007/s10016-006-9038-7
Flondell-Site D, Lindblad B, Kolbel T, et al. Markers of proteolysis, fibrinolysis and coagulation in relation to size and growth rate of abdominal aortic aneurysms. Vasc Endovasc Surg 2010;44:262-8.
DOI: 10.1177/1538574410361971
Freestone T, Turner RJ, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1995;15:1145-51.
DOI: 10.1161/01.ATV.15.8.1145
Petersen E, Wagberg F, Angquist KA. Does lipoprotein(a) inhibit elastolysis in abdominal aortic aneurysms? Eur J Vasc Endovasc Surg 2003;26:423-8.
DOI: 10.1016/S1078-5884(03)00178-3
Eugster T, Huber A, Obeid T, Schwegler I, et al. Aminoterminal propeptide of type III procollagen and matrix metalloproteinases-2 y -9 failed to srve as serum markers for abdominak aortic aneurysm. Eur J Vasc Endovasc Surg 2005;29:378-82.
DOI: 10.1016/j.ejvs.2004.12.007
Vega de Céniga M, Esteban M, Quintana JM, et al. Search for serum biomarkers associated with abdominal aortic aneurysm growth-a pilot study. Eur J Vasc Endovasc Surg 2009;37:297-9.
DOI: 10.1016/j.ejvs.2008.11.014
Hackmann AE, Rubin BG, Sánchez LA, et al. A randomized , placebo-controlled trial of doxycycline after endoluminal aneurysm repair. J Vasc Surg 2008;48:519-26.
DOI: 10.1016/j.jvs.2008.03.064
Baxter BT, Pearce WH, Waltke EA, et al. Prolonged administration o doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a a prospective (Phase II) multicenter study. J Vasc Surg 2002;36:1-12.
DOI: 10.1067/mva.2002.125018
Armstrong PJ, Johanning JM, Calton WC, et al. Differential gene expression in human abdominal aorta: Aneurysmal versus occlusive disease. J Vasc Surg 2002;35:346-55.
DOI: 10.1067/mva.2002.121071
Annabi B, Shedid D, Ghosn P, et al. Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms. J Vasc Surg 2002;35:539-46.
DOI: 10.1067/mva.2002.121124
Hovsepian DM, Ziporin SJ, Sakurai MK, et al. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. JVIR 2000;11:1245-52.
DOI: 10.1016/S1051-0443(07)61315-3
Speelman L, Hellenthal FA, Pulinx B, et al. The influence of wall stress on AAA growth and biomarkers. Eur J vasc Endovasc Surg 2010;39:410-6.
DOI: 10.1016/j.ejvs.2009.12.021
Lindholt JS, Vammen S, Fasting H, et al. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovas Surg 2000;20:281-5.
DOI: 10.1053/ejvs.2000.1151
Wilson WRW, Anderton M, Choke EC, et al. Elevated plasma MMP1 and MMP9 and associated with abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg 2008;35:580-4.
DOI: 10.1016/j.ejvs.2007.12.004
Memon AA, Zarrouk M, Agren-Wittechus S, et al. Identification of novel diagnostic and prognostic biomarkers for abdominal aortic aneurysm. Eur J Prev Cardiol 2020;27:132-42.
DOI: 10.1177/2047487319873062
Lindholt JS, Erlandsen EJ, Hennenberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms. Br J Surg 2001;88:1472-5.
DOI: 10.1046/j.0007-1323.2001.01911.x
Zhang J, Sun J, Lindholt JS, et al. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circ Res 2011;108:1316-27.
DOI: 10.1161/CIRCRESAHA.111.243758
Giusti B, Saracini C, Boli P, et al. Genetic analysis of 56 plymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet 2008;45:721-30.
DOI: 10.1136/jmg.2008.057851
Arapoglou V, Kondi-Pafiti A, Rizos D, et al. The influence of total plasma homocysteine and traiditional atherosclerotic risk factor son degree of abdominal aortic aneurysm tissue inflammation. Vasc Endovasc Surg 2009;43:473-9.
DOI: 10.1177/1538574409334345
Peeters AC, Van Landeghem BA, Graafsma SJ, et al. Low vitamin B6, and not plasma homocysteine concentration, as risk factor for abdominal aortic aneurysm: a retrospective case-control study. J Vasc Surg 2007;45:701-5.
DOI: 10.1016/j.jvs.2006.12.019
Brunelli T, Prisco D, Fedi S, et al. High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg 2000;32:531-6.
DOI: 10.1067/mva.2000.107563
Warsi AA, Davies B, Morris-Stiff G, et al. Abdominal aortic aneurysm and its correlation to plasma homocysteine and vitamins. Eur J Vasc Endovasc Surg 2004;27:75-9.
DOI: 10.1016/j.ejvs.2003.09.001
Engstrom G, Borner G, Lindblad B, et al. Incidence of fatal or repaired abdominal aortic aneurysm in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2004;24:337-41.
DOI: 10.1161/01.ATV.0000113292.00300.55
Lamblin N, Ratajczak P, Hot D, et al. Profile of macrophages in human abdominal aortic aneurysms: a transcriptomic, proteomic, and antibody protein array study. J Proteome Res 2010;9:3720-9.
DOI: 10.1021/pr100250s
Houard X, Touat Z, Ollivier V, et al. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 2009;82:532-41.
DOI: 10.1093/cvr/cvp048
Groeneveld ME, Struik JA, Musters RJP, et al. The potential role of neutrophil gelatinase-associated lipocalin in the development of abdominal aortic aneurysms. Ann Vasc Surg 2019;57:210-9.
DOI: 10.1016/j.avsg.2018.11.006
Powell JT, Sweeting MJ, Brown LC, et al. Systematic review and meta-analysis of growth rates of small abdominal aortic aneurysms. Br J Surg 2011;98:609-18.
DOI: 10.1002/bjs.7465
Parry DJ, Al-Barjas HS, Chapell L, et al. Markers of inflammation in men with small abdominal aortic aneurysm. J Vasc Surg 2010;52:145-51.
DOI: 10.1016/j.jvs.2010.02.279
De haro J, Acin F, Bleda S, et al. Prediction of asymptomatic abdominal aortic aneurysm expansión by means of rate of variation of C-reactive protein plasma levels. J Vasc Surg 2012;5:45-52.
DOI: 10.1016/j.jvs.2012.01.003
Seronie-Vivien S, Delanaye P, Pieroni L, et al. Cystatin C: crrent position and future prospects. Clin Chem Lab Med 2008;46(12):1664-86.
DOI: 10.1515/CCLM.2008.336
Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999;104(9):1191-7.
DOI: 10.1172/JCI7709
Lindholt JS, Martín-Ventura JL, Urbonavicius S, et al. Insulin-like growth factor I-a novel biomarker of abdominal aortic aneurysms. Atherosclerosis 2011;214:486-9.
Krishna SM, Seto SW, Jose R, et al. High serum thrombospondin-1 concentration is associated with slower abdominal aortic aneurysm growth and deficiency of thrombospondin-1promotes angiotensin II induced aortic aneurysm in mice. Clin Sci 2017;131:1261-81.
DOI: 10.1042/CS20160970
Duftner C, Seiler R, Dejaco C, et al. Antiphospholipid antibodies predict progression of abdominal aortic aneurysms. PloS One 2014;9:e99302.
DOI: 10.1371/journal.pone.0099302
Martinez-Pinna R, Ramos-Mozo P, Madrigal-Matute J, et al. Identification of peroxiredoxin-1 as novel biomarker of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2011;31:935-43.
DOI: 10.1161/ATVBAHA.110.214429
De Céniga MV, Esteban M, Barba A, et al. Assessment of biomarkers and predictive model for short-term prospective abdominal aortic aneurysm growth-a pilt study. Ann Vasc Surg 2014;28:1642-8.
DOI: 10.1016/j.avsg.2014.02.025
Sundermann AC, Saum K, Conrad KA, et al. Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth. Bood Adv 2018;2:3088-96.
DOI: 10.1182/bloodadvances.2017013359
Kristensen KL, Dahl M, Rasmussen LM, et al. Glycated hemoglobin is asscociated with the growth rate of abdominal aortic aneurysms: a substudy from the VIVA (Viborg Vascular) randomized screening tria. Arterioscler Thromb Vasc Biol 2017;37:730-6.
DOI: 10.1161/ATVBAHA.116.308874
Vuruskan E, Saracoglu E, Duzen IV. Serum bilirubin levels and the presence and progression of abdominal aortic aneurysms. Angiology 2017;68:428-32.
DOI: 10.1177/0003319716660240
Burillo E, Lindholt JS, Molina-Sánchez P, et al. ApoA1/HDLc levels are inversely asscoaited with abdominal aortic aneurysm progression. Thromb Haemost 2015;113:1335-46.
DOI: 10.1160/TH14-10-0874
Hinterseher I, Kuffner H, Berth H, et al. Long-term quality of life of abdominal aortic aneurysm patients under surveillance or after operative treatment. Ann Vasc Surg 2013;27:553-61.
DOI: 10.1016/j.avsg.2012.05.028
Propranolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 2002;35:72-9.
DOI: 10.1067/mva.2002.121308
Lindholt JS, Heegaard NH, Vammen S, et al. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidized LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2001;21:51-6.
DOI: 10.1053/ejvs.2000.1262
Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American association for vascular surgery/Society for vascular surgery, Society for cardiovascular angiography and interventions, Society for vascular medicine and biology, Society of interventional radiology, and the ACC/AHA Task Force on practice Guidelines. Circulation 2006;113:463-654.
DOI: 10.1161/CIRCULATIONAHA.106.174526
García-Prieto J, Villena-Gutiérrez R, Gómez M, et al. Neutrophil stunning by metoprolol reduces infarct size. Nat Commun 2017;8:14780.
DOI: 10.1038/ncomms14780
Zhang SL, Du X, Chen YQ, et al. Potential medication treatment according to pathological mechanisms in abdominal aortic aneurysm. J Cardiovasc Pharmacol 2018;71:46-57.
DOI: 10.1097/FJC.0000000000000540
Bicknell D, Kiru G, Falaschetti E, et al. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK). Eur Heart J 2016;37:3213-21.
DOI: 10.1093/eurheartj/ehw257
Yokokura H, Hiromatsu S, Akashi H, et al. Effects of calcium channel blocker azelnidipine on experimental abdominal aortic aneurysms. Surg Today 2007;37:468-73.
DOI: 10.1007/s00595-006-3367-6
Wemmelund H, Jorgenssen TM, Hogh A, et al. Low-dose aspirin and rupture of abdominal aortic aneurysm. J Vasc Surg 2016;65:616-25.
DOI: 10.1016/j.jvs.2016.04.061
Steinmetz EF, Buckley C, Shames ML, et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 2005;241:92-101.
DOI: 10.1097/01.sla.0000150258.36236.e0
Hurks R, Hoefer IE, Vink A, et al. Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. Eur J Vasc Endovasc Surg 2010;39:569-76.
DOI: 10.1016/j.ejvs.2010.01.030
Gottsater A, Flondell-Site D, Kolbel T, et al. Associations between statin treatment and markers of inflammation, vasoconstriction, and coagulation in patients with abdominal aortic aneurysm. Vasc Endovasc Surg 2008;42:567-73.
DOI: 10.1177/1538574408320027
Thanigaimani S, Singh T, Unosson J, et al. Association Between Metformin Prescription and Abdominal Aortic Aneurysm Growth and Clinical Events: a Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg 2021;62:747-56.
DOI: 10.1016/j.ejvs.2021.06.013
Gouveia e Melo R, Rodrigues M, Caldeira D, et al. Doxycycline is not Effective in Reducing Abdominal Aortic Aneurysm Growth: A Mini Systematic Review and Meta-Analysis of Randomised Controlled Trials. Eur J Vasc Endovasc Surg 2021;61:863-4.
DOI: 10.1016/j.ejvs.2021.01.023
Nana P, Dakis K, Brodis A, et al. Circulating Biomarkers for the Prediction of abdminal aortic aneurysm growth. Clin Med 2021;10:1718.
Alexander K, Ikonomidis J, Akerman A. New directions in diagnostics for aortic aneurysms: biomarkers and machine learning. Clin Med 2024;13:818.
DOI: 10.3390/jcm13030818